Skip to Main Content

Paper Details

The prophylactic and therapeutic efficacy of the broadly active antiviral ribonucleoside N<sup>4</sup>-Hydroxycytidine (EIDD-1931) in a mouse model of lethal Ebola virus infection.
Antiviral Res
4
2023
Author NameAffiliation
Alexander N FreibergUniversity of Texas Medical Branch, 301 University Boulevard, USA The Center for Biodefense and Emerging Infectious Diseases, University of Texas Medical Branch at Galveston, USA Sealy Institute for Vaccine Sciences, USA Institute for Human Infections and Immunity
  • 1 - 1

Datasets